AAAAAA

   
Results: 1-16 |
Results: 16
BIOLOGICAL CONSEQUENCES OF A POINT MUTATION AT CODON-969 OF THE FMS GENE
Authors: MCGLYNN H BAKER AH PADUA RA
Citation: H. Mcglynn et al., BIOLOGICAL CONSEQUENCES OF A POINT MUTATION AT CODON-969 OF THE FMS GENE, Leukemia research, 22(4), 1998, pp. 365-372
THE EFFECT OF ADENOVIRAL GENE-TRANSFER OF MMP AND TIMP ON A RENAL-CELL LINE
Authors: MCELLIGOTT AM BAKER AH MCGLYNN H
Citation: Am. Mcelligott et al., THE EFFECT OF ADENOVIRAL GENE-TRANSFER OF MMP AND TIMP ON A RENAL-CELL LINE, British Journal of Cancer, 78, 1998, pp. 55-55
MMP-2 AND MMP-9 IN HUMAN BREAST CARCINOMAS
Authors: MCCARTHY K MAGUIRE T MCELLIGOTT AM MCGLYNN H MCGREAL G MCDERMOTT E OHIGGINS N DUFFY MJ
Citation: K. Mccarthy et al., MMP-2 AND MMP-9 IN HUMAN BREAST CARCINOMAS, British Journal of Cancer, 78, 1998, pp. 64-64
PHORBOL ESTER-INDUCED ALTERATIONS IN THE METASTATIC PROFILE OF A RENAL-CANCER CELL-LINE
Authors: MORROW DMP MCELLIGOTT AM FARRAGHER SM MCGLYNN H
Citation: Dmp. Morrow et al., PHORBOL ESTER-INDUCED ALTERATIONS IN THE METASTATIC PROFILE OF A RENAL-CANCER CELL-LINE, British Journal of Cancer, 78, 1998, pp. 73-73
TISSUE INHIBITOR OF METALLOPROTEINASE GENE-EXPRESSION - A TARGET FOR GENE-THERAPY IN RENAL-CELL CARCINOMA
Authors: MCELLIGOTT AM BAKER AH MCGLYNN H
Citation: Am. Mcelligott et al., TISSUE INHIBITOR OF METALLOPROTEINASE GENE-EXPRESSION - A TARGET FOR GENE-THERAPY IN RENAL-CELL CARCINOMA, Cancer gene therapy, 4(5), 1997, pp. 300-300
ANTIOXIDANT PREVENTION OF TUMOR PROMOTER INDUCED-INHIBITION OF INTERCELLULAR COMMUNICATION IN RENAL-CELL LINES
Authors: MORROW DMP MCGLYNN H
Citation: Dmp. Morrow et H. Mcglynn, ANTIOXIDANT PREVENTION OF TUMOR PROMOTER INDUCED-INHIBITION OF INTERCELLULAR COMMUNICATION IN RENAL-CELL LINES, Biochemical Society transactions, 25(4), 1997, pp. 561-561
ALLELIC LOSS OF THE FMS GENE IN ACUTE MYELOID-LEUKEMIA
Authors: MCGLYNN H KAPELKO K BAKER A BURNETT A PADUA RA
Citation: H. Mcglynn et al., ALLELIC LOSS OF THE FMS GENE IN ACUTE MYELOID-LEUKEMIA, Leukemia research, 21(10), 1997, pp. 919-923
MATRIX METALLOPROTEINASE REGULATION IN RENAL-CANCER
Authors: MCELLIGOTT A BAKER AH MCGLYNN H
Citation: A. Mcelligott et al., MATRIX METALLOPROTEINASE REGULATION IN RENAL-CANCER, British Journal of Cancer, 74, 1996, pp. 26-26
IN-VITRO MODEL FOR ASSESSING TUMOR PROMOTER ACTIVITY
Authors: MORROW D RYAN MP MCGLYNN H
Citation: D. Morrow et al., IN-VITRO MODEL FOR ASSESSING TUMOR PROMOTER ACTIVITY, British Journal of Cancer, 74, 1996, pp. 42-42
RAS AND FMS MUTATIONS FOLLOWING CYTOTOXIC THERAPY FOR CHILDHOOD ACUTELYMPHOBLASTIC-LEUKEMIA
Authors: TAYLOR C MCGLYNN H CARTER G BAKER AH WARREN N RIDGE SA OWEN G THOMPSON E THOMPSON PW JACOBS A PADUA RA
Citation: C. Taylor et al., RAS AND FMS MUTATIONS FOLLOWING CYTOTOXIC THERAPY FOR CHILDHOOD ACUTELYMPHOBLASTIC-LEUKEMIA, Leukemia, 9(3), 1995, pp. 466-470
A C-TERMINAL FMS MUTATION IN A PATIENT WITH B-CELL MALIGNANCY
Authors: BAKER AH BALL S MCGLYNN H WHITTAKER JA BURNETT AK PADUA RA
Citation: Ah. Baker et al., A C-TERMINAL FMS MUTATION IN A PATIENT WITH B-CELL MALIGNANCY, Leukemia, 9(1), 1995, pp. 155-158
FMS MUTATIONS IN PATIENTS FOLLOWING CYTOTOXIC THERAPY FOR LYMPHOMA
Authors: BAKER A CACHIA P RIDGE S MCGLYNN H CLARKE R WHITTAKER J JACOBS A PADUA RA
Citation: A. Baker et al., FMS MUTATIONS IN PATIENTS FOLLOWING CYTOTOXIC THERAPY FOR LYMPHOMA, Leukemia research, 19(5), 1995, pp. 309-318
FMS PROMOTER STUDIES IN B-LYMPHOCYTES
Authors: BAKER AH MCGLYNN H CONLON FV PADUA RA
Citation: Ah. Baker et al., FMS PROMOTER STUDIES IN B-LYMPHOCYTES, Blood, 84(10), 1994, pp. 10000599-10000599
IN-VITRO MECHANISMS AND MODELS OF GENTAMICIN-NEPHROTOXICITY
Authors: MCGLYNN H RYAN MP
Citation: H. Mcglynn et Mp. Ryan, IN-VITRO MECHANISMS AND MODELS OF GENTAMICIN-NEPHROTOXICITY, Toxicology in vitro, 7(4), 1993, pp. 407-410
COLONY-STIMULATING FACTOR-I RECEPTOR (CSF-1R) INTERNALIZATION STUDIESIN HEMATOPOIETIC-CELLS
Authors: MCGLYNN H BAKER AH DIBB NJ BURNETT AK PADUA RA
Citation: H. Mcglynn et al., COLONY-STIMULATING FACTOR-I RECEPTOR (CSF-1R) INTERNALIZATION STUDIESIN HEMATOPOIETIC-CELLS, Experimental hematology, 21(8), 1993, pp. 1182-1182
FMS MUTATIONS IN PATIENTS IN REMISSION FOLLOWING CYTOTOXIC THERAPY FOR LYMPHOMA AND CHILDHOOD LEUKEMIA
Authors: MCGLYNN H BAKER AH RIDGE SA CACHIA PG WHITTAKER JA BURNETT AK PADUA RA
Citation: H. Mcglynn et al., FMS MUTATIONS IN PATIENTS IN REMISSION FOLLOWING CYTOTOXIC THERAPY FOR LYMPHOMA AND CHILDHOOD LEUKEMIA, Blood, 82(10), 1993, pp. 10000035-10000035
Risultati: 1-16 |